As of 4:00pm ET
| -0.25 / -4.95%|
The 1 analysts offering 12-month price forecasts for Juniper Pharmaceuticals Inc have a median target of 13.00, with a high estimate of 13.00 and a low estimate of 13.00. The median estimate represents a +170.83% increase from the last price of 4.80.
The current consensus among 1 polled investment analysts is to Hold stock in Juniper Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.